Skip to content

Evaluation of intervention effect of rock salt aerosol on occupational pneumoconiosis patients

Evaluation of intervention effect of rock salt aerosol on occupational pneumoconiosis patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078339
Enrollment
Unknown
Registered
2023-12-05
Start date
2024-01-01
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Occupational pneumoconiosis

Interventions

Group 1:Inhalation of salt aerosol at 0mg/m3, 1 hour per session, once a day, 14 days per cycle, continuous treatment for 2 cycles
Group 2:Inhalation of salt aerosol at 4mg/m3, 1 hour per session, once a day, 14 days per cycle, continuous treatment for 2 cycles
Group 3:Inhalation of salt aerosol at 8mg/m3, 1 hour per session, once a day, 14 days per cycle, continuous treatment for 2 cycles
Group 4:Inhalation of salt aerosol at 12mg/m3, 1 hour per session, once a day, 14 days per cycle, continuous treatment for 2 cycles
Group 5:Inhalation of salt aerosol at 16mg/m3, 1 hour per session, once a day, 14 days per cycle, continuous treatment for 2 cycles

Sponsors

WeiChunlong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Pneumoconiosis patients confirmed by diagnostic criteria for pneumoconiosis,Sign informed consent and be willing to participate in the study

Exclusion criteria

Exclusion criteria: Pregnancy or pregnancy, recent severe lung infection, malignant tumor, serious damage of heart, liver and kidney, and active tuberculosis and other infectious diseases

Design outcomes

Primary

MeasureTime frame
pulmonary function;

Secondary

MeasureTime frame
Immune indicators (IgG, IgA);

Countries

China

Contacts

Public ContactJi Xiaoqing

Nanjing Prevention and Treatment Center for Occupational Diseases

sophie_jxq@126.com+86 15850605019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026